🔎 Trials Near Me

Gara Jalqabaatti › Kansa Endometiriyaalii › Texas › Austin

Qorannoo klinikaalii Kansa Endometiriyaalii Austin, TX keessatti

Qorannoo 15 Kansa Endometiriyaalii f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06270706

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology, Austin
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06586957

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • USOR - Texas Oncology, Austin
  • USOR - Texas Oncology, Austin
  • USOR - Texas Oncology- Austin North, Austin
Umuriin 18 fi ol · Dubartoota · Haaromfame 09-Ful-2026 · NCT07166094

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07383506

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology - Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology - Central / South Texas, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology - Central/South Texas, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Austin
Umuriin 18 fi ol · Dubartoota · Haaromfame 29-Ado-2026 · NCT07044336

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Texas LLC - Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT07503808

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Elligo Health Research, Inc., Austin
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Namoota walitti qabaa jiraSadarkaa 1
  • Dren Investigational Site, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06999187

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Namoota walitti qabaa jiraSadarkaa 2/3
  • Texas Oncology-Austin Central, Austin
Umuriin 18 fi ol · Dubartoota · Haaromfame 02-Cam-2024 · NCT05797831

Qorannoo Kansa Endometiriyaalii magaalota biroo keessatti

Qorannoo biroo Austin keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.